Comparative study of intravenous diuretics therapy-bolus versus infusion regimen in acute decompensated heart failure


  • Sanjeev Diwakar Consultant Physician, Park Hospital, Vishnu Garden, New Delhi, India
  • Rahul Kumar Consultant Physician, Park Hospital, Vishnu Garden, New Delhi, India



Acute decompensated heart failure, Serum sodium, Serum potassium, Intravenous diuretics therapy, Bolus, infusion


Background: Heart failure (HF) is a growing problem worldwide; more than 20 million people around the world are affected. The objective of the study was to compare the effect of different modes of administration of intravenous diuretic –bolus versus infusion, in acute decompensated heart failure in relation to diuresis and electrolyte balance.

Methods: This prospective study was conducted in Darbhanga Medical College and hospital, Laheria sarai between October 2014 to November 2016. Patients of acute decompensated heart failure attending medical emergency ward and Intensive care unit of medicine department of Darbhanga Medical College and hospital, Laheria sarai were selected and grouped randomly as per inclusion and exclusion criteria.

Results: The main findings of our study were greater diuresis in the first 24 h of admission with bolus dose. No difference in serum sodium or serum potassium levels between the groups.

Conclusions: All three modes of diuretic therapies can be practiced with no difference in worsening of electrolyte levels. Bolus dose administration with its rapid volume loss might be a more effective diuretic strategy in our country with limited health resources. 


Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, KonstamMA, et al. Acute heart failure syndromes: current stateand framework for future research. Circulation. 2005;112(25):3958-68.

Opasich C, Rapezzi C, Lucci D, Gorini M, Pozzar F, ZanelliE, et al. Precipitating factors and decision-making processes ofshort-term worsening heart failure despite “optimal” treatment (from the IN-CHF Registry). Am J Cardiol. 2001;88(4):382.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH et al. Factors identified asprecipitating hospital admissions for heart failure and clinicaloutcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008;168(8):847-54.

Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomesof patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated HeartFailure National Registry (ADHERE). Am Heart J. 2005;149(2):209-16.

National Commission on Population, Government of India. 2010. Accessed on

Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, et al. Lifetime riskfor developing congestive heart failure: The Framingham Heart Study. Circulation. 2002;106:3068-72.

World Health Organization. Geneva: Switzerland: The WHO Global InfoBase. Available at Accessed on 3rd March, 2010.

Freda BJ, Slawsky M, Mallidi J. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis. 2011;58.

Jessup M, Abraham WT, Casey DE. 2009 Focused update: ACCF/AHA Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119.

Adams KF, Lindenfeld J, Arnold JM. HFSA 2006comprehensive heart failure practice guideline. J Card Fail. 2006;12:1e119.

The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J. 1997;18:736e-53.

Salvador DRK, Punzalan FE, Ramos GC. Continuous infusion versus bolus injection of loop diuretics in congestive heartfailure (Review). Cochrane Database Syst Rev. 2009;1:CD003178.

Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB. Continuous versus intermittent infusion offurosemide in acute decompensated heart failure. J Card Fail. 2010;16:188e193.

Pivac N, Rumboldt Z, Sardelic S. Diuretic effects of furosemide infusion versus bolus injection in congestiveheart failure. Int J Clin Pharmacol Res. 1998;18:121e-8.

Licata g, Di Pasquare P, Parrinello G. Effects of high-dose furosemide and small volume hypertonic saline solution infusion in comparision with a high dose of furosemide as bolus. Am Heart J. 2003;145:459-66.

Amer M, Adomaityte J, Qayyum R. Continuous infusion versus intermittent bolus furosemide in ADHF:an Updated meta-analysis of randomazied control trials. J Hosp Med. 2012;7:270-5.

Ruchit SA, Vijaykumar S, Lakshmanananitha. A prospective randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure. Indian Heart J. 2014;66:309-16.

Felker GM, Lee KL, Bull DA. Diuretic strategies inpatients with acute decompensated heart failure. N Engl JMed. 2011;364.

ShahRv, McNulty S, O´connor CM. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimisation strategies in acute heart failure. Am Heart J. 2012;164:862-8.

Gregory G, Javed B, Randal SC. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail. 2010;16.

Emad AF, Carlos AL, Eyal H. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days. Hellenic J Cardiol. 2011;52.






Original Research Articles